|
Volumn 58, Issue 9, 2009, Pages 445-452
|
New perspectives in medical approach to therapy of head and neck squamous cell carcinoma.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
NEW DRUG;
ARTICLE;
CLINICAL TRIAL;
FORECASTING;
GENE THERAPY;
HEAD AND NECK TUMOR;
HUMAN;
IMMUNOTHERAPY;
MULTIMODALITY CANCER THERAPY;
SQUAMOUS CELL CARCINOMA;
ANTIBODIES, MONOCLONAL;
CARCINOMA, SQUAMOUS CELL;
CLINICAL TRIALS AS TOPIC;
COMBINED MODALITY THERAPY;
DRUGS, INVESTIGATIONAL;
FORECASTING;
GENE THERAPY;
HEAD AND NECK NEOPLASMS;
HUMANS;
IMMUNOTHERAPY;
|
EID: 77951928443
PISSN: 00264970
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (0)
|